
Keywords: Epidermal growth factor (EGF); Akt; LY294002 (PI3 K inhibitor); PD98059 (MAP kinase inhibitor); Mammalian target of rapamycin (mTOR)EGF, Epidermal growth factor; EGFR, Epidermal growth factor receptor; PDK1, Phosphoinositide dependent kinase 1; ERK, Extra